White Papers
-
Breaking Through Barriers With Integrated Trial Optimization
5/9/2025
In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.
-
What Clinical Trial Decision Makers Are Prioritizing In 2025
5/7/2025
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
American Academy Of Ophthalmology IRIS Registry Report
5/1/2025
The 2024 IRIS® Registry Industry Report showcases the transformative power of real-world data (RWD) in ophthalmology.
-
A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights
4/22/2025
In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.
-
Patient-Reported Outcome In Oncology Clinical Trials
4/17/2025
As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.
-
Global Trial Disclosure Landscape Grows Increasingly Complex
4/15/2025
The industry is witnessing a global trend toward increased transparency and more stringent enforcement of clinical trial reporting requirements. However mechanisms and penalties differ significantly across regions and countries.
-
How Digitized Protocols Are Accelerating Clinical Research
4/15/2025
Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.
-
Accelerate Respiratory Disease Trials: A Guide To Digital Endpoints
4/15/2025
Learn how wearables and DHTs are alleviating the trial participation burden, increasing the likelihood of trial success, and enhancing the overall management of these conditions.
-
The Rescue Option: Course Correcting Struggling Clinical Trials
4/14/2025
The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.
-
Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology
4/11/2025
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.